An analysis of the largest recorded cohort of patients with invasive lobular breast cancer (ILBC) demonstrates that outcomes are significantly worse when compared with invasive ductal breast cancer, ...

A recent study found that breast cancer–specific survival in patients with invasive lobular carcinoma was inferior compared to patients with invasive ductal carcinoma. A recent study found that breast ...

It’s taken a few years, but lobular breast cancer has finally made its way into the research spotlight. The second-most common type of breast cancer after ductal or NST (no specific type), invasive ...

Different maintenance strategies versus observation in patients with hormone receptor-positive metastatic breast cancer after first-line chemotherapy: A real-world study and meta-analysis. CDK 4/6 ...

Please provide your email address to receive an email when new articles are posted on . Lobular breast cancer would be the seventh most common malignancy among women in the U.S. if ranked separately ...

Dalpiciclib in combination with letrozole/anastrozole or fulvestrant in HR+/HER2- advanced breast cancer: A phase Ib study. Hormone therapy (HT) or capecitabine (CAP) as maintenance therapy following ...

Please provide your email address to receive an email when new articles are posted on . Despite being the second most prevalent histologic subtype of invasive breast cancer in the U.S., invasive ...

When former public affairs consultant Leigh Pate was diagnosed with lobular breast cancer in 2013, she mistakenly thought it was called “globular.” She’d never heard of it before, even though lobular ...

In an attempt to find out why the long-term outcomes are poorer for patients with lobular breast cancer -- which affects some 40,000 women a year -- researchers began looking at the role of the ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A lesser-known type of breast cancer is on the rise among women in the ...